Pacific Biosciences of California, Inc. last reported quarterly results on Nov 4, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $40.6 million (+5.5% year over year) and diluted EPS of -$0.12. It usually reports 12–37 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 11, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Monday. Based on last year's release for the same quarter on Jan 12, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 12–37 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 4, 2026
35 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
41
+5.5%
|
-38
+0.4%
|
-0.12
+7.7%
|
|
Aug 5, 2026
36 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
39
-1.9%
|
-45
-6.7%
|
-0.14
+0.0%
|
|
May 7, 2026
37 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
37
+0.1%
|
-8
+98.1%
|
-0.03
+97.9%
|
|
Jan 12, 2026
12 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
45
|
-40
-1802.7%
|
-0.13
-2006.5%
|
|
Nov 5, 2025
36 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
38
-3.8%
|
-38
+37.4%
|
-0.13
+40.9%
|
|
Aug 7, 2025
38 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
40
+10.4%
|
-42
+75.8%
|
-0.14
+78.1%
|
|
Apr 9, 2025
9 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
37
-4.3%
|
-426
-445.0%
|
-1.44
-396.6%
|
|
Jan 14, 2025
14 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
—
|
2
+102.9%
|
0.01
+102.3%
|
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- PACB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Menlo Park, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1299130
- Former names
- PACIFIC BIOSCIENCES OF CALIFORNIA INC (until Feb 5, 2013); NANOFLUIDICS INC (until Jul 28, 2004)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Source: SEC EDGAR filings. This is company-reported data, not investment advice.